AI-driven innovation and creation, built for discovery
Turn biological insights into clinical candidates with AI-driven molecular design and integrated discovery systems, engineered to cure disease.
Al-powered Discovery Engine
Translate targets into transformative therapies
35 Billion Molecule Screening Library
Library of novel, diverse, synthetically accessible with drug-like properties enabling a broad exploration of target space
3D Configuration Molecular Descriptor
An Al-integrated 3D active conformation detection algorithm that precisely models molecular 3D structures for improved drug properties calculation
Activity-ActConf-Druggability Prediction Models
An integrated DL/ML framework for pan-target activity prediction, active conformation detection and druggability appraisals
Pivotal Phase 3 success in China, NDA accepted for review
Phase 1 objectives achieved, Phase 2 ready
INDs filed with CDE, cleared for clinical initiation
Optimized Structural Profiles for Ideal Therapeutic Outcomes
Seamless integration of AI-driven molecular design with wet assay validation facilitates rapid, economical translation into clinical practice
-
Billions of data mined continuously for novel insights
-
Molecules to candidates: novel MOAs, diverse scaffolds, accelerated timelines
-
Experimental data feeds back to refine predictive models